| __timestamp | Galapagos NV | Mesoblast Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 55305000 |
| Thursday, January 1, 2015 | 129714000 | 77593000 |
| Friday, January 1, 2016 | 139574000 | 50013000 |
| Sunday, January 1, 2017 | 218502000 | 58914000 |
| Monday, January 1, 2018 | 322876000 | 65927000 |
| Tuesday, January 1, 2019 | 427320000 | 59815000 |
| Wednesday, January 1, 2020 | 523667000 | 56188000 |
| Friday, January 1, 2021 | 491707000 | 53012000 |
| Saturday, January 1, 2022 | 515083000 | 32815000 |
| Sunday, January 1, 2023 | 241294000 | 27189000 |
| Monday, January 1, 2024 | 25353000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Galapagos NV and Mesoblast Limited have shown contrasting trends in their R&D investments. From 2014 to 2023, Galapagos NV consistently outspent Mesoblast Limited, with its R&D expenses peaking in 2020 at over 500% of Mesoblast's spending that year. However, by 2023, Galapagos NV's R&D expenses had decreased by more than 50% from its 2020 peak, while Mesoblast Limited maintained a steadier, albeit smaller, investment. This divergence highlights the strategic differences between the two companies, with Galapagos NV experiencing more volatility in its R&D budget. As we look to the future, the missing data for 2024 leaves us wondering how these trends will evolve and what it means for the biotech landscape.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Mesoblast Limited
Comparing Innovation Spending: Gilead Sciences, Inc. and Galapagos NV
Intra-Cellular Therapies, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Galapagos NV
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Amneal Pharmaceuticals, Inc. or Mesoblast Limited: Who Invests More in Innovation?
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Galapagos NV
R&D Insights: How Mesoblast Limited and Celldex Therapeutics, Inc. Allocate Funds